… study showed that erlotinib and gefitinib had similar effectiveness but gefitinib had a better
safety profile compared to erlotinib… for NSCLC patients compared to erlotinib. However, further …

… if the comparative effects of gefitinib versus erlotinib would vary with these important clinical
factors and to explore the source of substantial heterogeneity, if present. Sensitivity analyses …

… In conclusion, the present study suggested radiotherapy plus erlotinib should be a
preferable modality compared with CCRT, with similar survival outcomes but better treatment …

… (gefitinib, erlotinib, … , erlotinib, or afatinib is most appropriate as a first-line therapy is still a
controversial issue. The aim of this study was to compare the effectiveness of gefitinib, erlotinib, …

… Therefore, we aimed to study the interaction of OSI and the experimental drug KP2187 from
… Herein we report on an extensive comparative study of the EGFR inhibitors regarding their …

… erlotinib, and icotinib, are reported to be effective in patients with brain metastases. However,
direct comparative studies … to brain metastases more effectively than erlotinib or icotinib in a …

… rates compared with erlotinib (P<0.05). Erlotinib resulted in a significantly longer MST
compared with gefitinib and icotinib (P<0.05). In conclusion, gefitinib, erlotinib and icotinib had …

… with erlotinib compared with gefitinib. If confirmed, our results indicate that erlotinib may
play an important role in controlling CNS progression from EGFR mutation-positive NSCLC. …

… Almost all of the included studies did not show any differences in all anti-… study reported an
unfavorable result for erlotinib, with both lower PFS and OS, which might relate to the erlotinib …

… studies showed no differences in all indices of antitumor effectiveness, which was the basis
of our results. Only one study reported an unfavorable result against erlotinib, … in the erlotinib …